88 related articles for article (PubMed ID: 191583)
1. Carbon-13 nuclear magnetic resonance studies on a new antitubercular peptide antibiotic LL-BM547beta.
McGahren WJ; Morton GO; Kunstmann MP; Ellestad GA
J Org Chem; 1977 Apr; 42(8):1282-6. PubMed ID: 191583
[No Abstract] [Full Text] [Related]
2. 13C-nuclear magnetic magnetic resonance studies on viomycin and its related compounds.
Kitagawa T; Miura T; Mori K; Taniyama H; Kawano K; Kyogoku Y
Chem Pharm Bull (Tokyo); 1977 Feb; 25(2):280-4. PubMed ID: 192477
[No Abstract] [Full Text] [Related]
3. Roles of cyclic structure and dehydro-form amino acid residue in a peptide antibiotic.
Kitagawa T; Miura T; Taniyama H
J Biochem; 1977 Jun; 81(6):1759-67. PubMed ID: 197067
[No Abstract] [Full Text] [Related]
4. Conversion of (2S)-arginine to (2S,3R)-capreomycidine by VioC and VioD from the viomycin biosynthetic pathway of Streptomyces sp. strain ATCC11861.
Ju J; Ozanick SG; Shen B; Thomas MG
Chembiochem; 2004 Sep; 5(9):1281-5. PubMed ID: 15368582
[No Abstract] [Full Text] [Related]
5. Identification and cloning of genes encoding viomycin biosynthesis from Streptomyces vinaceus and evidence for involvement of a rare oxygenase.
Yin X; O'Hare T; Gould SJ; Zabriskie TM
Gene; 2003 Jul; 312():215-24. PubMed ID: 12909358
[TBL] [Abstract][Full Text] [Related]
6. Studies on viomycin. VIII. Selective modifications of the terminal amino groups of viomycin.
Kitagawa T; Miura T; Takaishi M; Taniyama H
Chem Pharm Bull (Tokyo); 1975 Sep; 23(9):2123-7. PubMed ID: 171092
[No Abstract] [Full Text] [Related]
7. Studies on viomycin IX. Amino acid derivatives on viomycin.
Kitagawa T; Miura T; Takaishi C; Taniyama H
Chem Pharm Bull (Tokyo); 1976 Jun; 24(6):1324-30. PubMed ID: 191204
[No Abstract] [Full Text] [Related]
8. Formation of the nonproteinogenic amino acid 2S,3R-capreomycidine by VioD from the viomycin biosynthesis pathway.
Yin X; McPhail KL; Kim KJ; Zabriskie TM
Chembiochem; 2004 Sep; 5(9):1278-81. PubMed ID: 15368581
[No Abstract] [Full Text] [Related]
9. Qualitative aspects of hydrogen-deuterium exchange in the 1H, 13C, and 15N nuclear magnetic resonance spectra of viomycin in aqueous solution.
Hawkes GE; Randall EW; Hull WE; Gattegno D; Conti F
Biochemistry; 1978 Sep; 17(19):3986-92. PubMed ID: 213101
[TBL] [Abstract][Full Text] [Related]
10. [Viomycin and viomycin pantothenate with reduced toxicity in therapy of pulmonary tuberculosis].
KUNTZ E
Arzneimittelforschung; 1957 Apr; 7(4):233-7. PubMed ID: 13436325
[No Abstract] [Full Text] [Related]
11. The total structure of viomycin, a tuberculostatic peptide antibiotic.
Bycroft BW; Cameron D; Croft LR; Johnson AW; Webb T; Hassanali-Walji A
Experientia; 1971 May; 27(5):501-3. PubMed ID: 4332116
[No Abstract] [Full Text] [Related]
12. Studies on viomycin. VII. Oxidative modifications of viomycin.
Kitagawa T; Miura T; Sawada Y; Fujiwara K; Ito R
Chem Pharm Bull (Tokyo); 1974 Aug; 22(8):1827-34. PubMed ID: 4371987
[No Abstract] [Full Text] [Related]
13. [Clinical tests of viomycin-pantothenatesulfate (vionactan-P)].
ARNOLD M
Schweiz Z Tuberc Pneumonol; 1958; 15(4):203-10. PubMed ID: 13602779
[No Abstract] [Full Text] [Related]
14. Enzyme immunoassay of viomycin. New cross-linking reagent for enzyme labelling and a preparation method for antiserum to viomycin.
Kitagawa T; Fujitake T; Taniyama H; Aikawa T
J Biochem; 1978 May; 83(5):1493-501. PubMed ID: 207686
[TBL] [Abstract][Full Text] [Related]
15. [Experimental studies in vitro with viomycin panthothenate].
COLOMBI GC; BASILICO F; TROTTA E
G Ital Della Tuberc; 1958; 12(4):197-201. PubMed ID: 13574580
[No Abstract] [Full Text] [Related]
16. [Experimental and clinical importance of pantothenates of streptomycin, dihydrostreptomycin and viomycin].
PREZIOSI P
Riforma Med; 1958 Aug; 72(33):931-3. PubMed ID: 13579974
[No Abstract] [Full Text] [Related]
17. [Streptomycin, dihydrostreptomycin, neomycin & viomycin pantothenates].
KELLER H
G Ital Chemioter; 1957; 4(1-2):33-57. PubMed ID: 13562573
[No Abstract] [Full Text] [Related]
18. [Viomycin pantothenate in therapy-resistant primary tuberculosis in small children].
RENOVANZ HD
Kinderarztl Prax; 1958 Jul; 26(7):289-95. PubMed ID: 13576684
[No Abstract] [Full Text] [Related]
19. Roles of VioG and VioQ in the incorporation and modification of the Capreomycidine residue in the peptide antibiotic viomycin.
Fei X; Yin X; Zhang L; Zabriskie TM
J Nat Prod; 2007 Apr; 70(4):618-22. PubMed ID: 17302456
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of primary tuberculous infection with viomycin pantothenate].
SIMON K
Pediatrie; 1958; 13(4):455-8. PubMed ID: 13600934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
